Moderna $1.5B investment aims to expand its vaccine franchise and achieve breakeven by 2028.
Browsing: Market & Financials
Market trends, financial performance, quarterly results, and investment insights from global pharma and biotech companies.
Scott Gottlieb joins UnitedHealth’s board, enhancing regulatory ties.
Sanofi AI ROI is about measurable improvements, not flashy demos, says CEO Paul Hudson.
WuXi AppTec revenue growth highlights its resilience as US sales increase by 31.9% amid easing restrictions.
Penicillin-G plant in Andhra Pradesh, with a capacity of 15,000 tonnes annually, inaugurated by PM Modi on 10 September 2025.
Strand Therapeutics promotes Prashant Nambiar to Chief Scientific Officer, enhancing leadership with his prior experience as Senior Vice President.
Zymeworks royalty-driven model aims to create consistent shareholder value following promising cancer drug data.
AstraZeneca Virginia investment enhances ADC production capabilities with a $500 million boost.
GSK CEO Luke Miels is set to lead the company into a pivotal growth phase starting January 2026.
Successful drug launches need realistic forecasts and market preparation, says Jason O’Neill, highlighting common pitfalls in new product launches.